New guidelines from the Medical Products Agency: the triple regime against Helicobacter pylori is necessary. Treat only if the ulcer is verified
Blomgren, K.; Alván, G.
Lakartidningen 93(11): 1041-2 1045
1996
ISSN/ISBN: 0023-7205 PMID: 8656812 Document Number: 465241
Document emailed within 1 workday
Related Documents
Sanfélix Genovés, J.; Pereiró Berenguer, I.; Jimeno Bernard, R.; García Tell, G.; Navarro Pérez, J.; Bonet Pla, A.; Ballester Belenguer, J. 1998: Helicobacter pylori: 6-day triple therapy in duodenal ulcer Atencion Primaria 21(8): 517-521Gisbert, J.P.; Boixeda, D.; Martín de Argila, C.; García Plaza, A. 1996: Why, when and how to treat Helicobacter pylori infection in gastroduodenal ulcer disease? Revista Clinica Espanola 196(9): 610-621
Labenz, J.; Gyenes, E.; Rühl, G.H.; Börsch, G. 1993: Oral triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease Medizinische Klinik 88(5): 297-299
Kullavanijaya, P.; Gonlachanvit, S.; Mahachai, V.; Kladchareon, N. 2000: Eradication of Helicobacter pylori with lansoprazole based triple therapy in peptic ulcer disease Journal of the Medical Association of Thailand 83(3): 230-235
Dorval, E.D.; Loulergue, J.; Barbieux, J.P.; Metman, E.H.; de Muret, A. 1991: Helicobacter pylori and duodenal ulcer. Long-term results of triple sucralfate antibiotic therapy Gastroenterologie Clinique et Biologique 15(11): 863-864
Karita, M.; Morshed, M.G.; Ouchi, K.; Okita, K. 1994: Bismuth-free triple therapy for eradicating Helicobacter pylori and reducing the gastric ulcer recurrence rate American Journal of Gastroenterology 89(7): 1032-1035
Zerbib, F. 1998: Helicobacter pylori et anti-inflammatoires non stéroïdiens Helicobacter pylori et reflux gastro-œsophagien - Helicobacter pylori and NSAID. Helicobacter pylori in GORD Hepato-Gastro (Montrouge) 5(FEV): 56-60
Gaidar, I.A.; Stepanova, E.V.; Mosiichuk, L.N.; Demeshkina, L.V.; Sheikhetova, G.A.; Bespalova, E.V.; Kudriavtseva, V.E.; Vcherashniaia, N.N. 2001: Particular features of the relationship of Helicobacter pylori and G cells in patients with duodenal ulcer, with special reference to the Helicobacter pylori strain Likars'ka Sprava 2001(4): 176-177
Beermann, Börn. 2006: Reply concerning the new Medical Products Agency's guidelines for primary prevention of cardiovascular diseases. Issuing recommendations based on available evidence basis an ethical duty Lakartidningen 103(47): 3731-3732
Aminian, K.; Farsad, F.; Ghanbari, A.; Fakhreih, S.; Hasheminasab, S.M. 2010: A randomized trial comparing four Helicobacter pylori eradication regimens: standard triple therapy, ciprofloxacin based triple therapy, quadruple and sequential therapy Tropical Gastroenterology: Official Journal of the Digestive Diseases Foundation 31(4): 303-307
Henry, A.; Batey, R.G. 1998: Low prevalence of Helicobacter pylori in an Australian duodenal ulcer population: NSAIDitis or the effect of ten years of H. pylori treatment? Australian and New Zealand Journal of Medicine 28(3): 345
Ren, Q.; Ma, B.; Yang, K.; Yan, X. 2010: Lafutidine-based triple therapy for Helicobacter pylori eradication Hepato-Gastroenterology 57: 102-103
Hu, P.-j. 2004: How to diagnose and treat the Helicobacter pylori infection Zhonghua Nei Ke Za Zhi 43(4): 243
Kumar, D.; Sinha, A.N. 2002: Helicobacter pylori infection delays ulcer healing in patients operated on for perforated duodenal ulcer Indian Journal of Gastroenterology: Official Journal of the Indian Society of Gastroenterology 21(1): 19-22
Chung, S.Jin.; Lee, D.Ho.; Kim, N.; Jung, S.Hyang.; Kim, J.Wook.; Hwang, J.Hyeok.; Park, Y.Soo.; Lee, K.Hyuk.; Jung, H.Chae.; Song, I.Sung. 2007: Eradication rates of helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease Hepato-Gastroenterology 54(76): 1293-1296
Flores, S.; Opazo, H.; Valderrama, D.; Aguilera, R.; Marchese, A.; Valderrama, S. 2000: Triple therapy of short-term with azithromycin, amoxycillin and omeprazole for the eradication of Helicobacter pylori Revista Medica de Chile 128(5): 509-512
Thong-Ngam, D.; Tangkijvanich, P.; Treeprasertsuk, S.; Wisedopas, N.; Kullavanijaya, P. 2002: Effectiveness of ranitidine bismuth citrate based triple therapy for treating Helicobacter pylori Journal of the Medical Association of Thailand 85(10): 1054-1059
Duggan, A.; Williamson, R. 1998: Efficacy of ranitidine bismuth citrate (RBC) dual and triple therapies for the eradication of Helicobacter pylori Gut 42(4): 596-597
Uthaisaengsook, W. 2003: Low dose, one-week triple therapy (lanzoprazole, amoxycillin, clarithromycin) for eradication of Helicobacter pylori infection Journal of the Medical Association of Thailand 86(7): 599-602
Cui, M.; Hu, F.; Jiang, H.; Zheng, X. 2002: Comparison of pantoprazole and omeprazole-based triple therapy regimens in the treatment of Helicobacter pylori infection Zhonghua Yi Xue Za Zhi 82(18): 1245-1248